Sign in
4

Changes in Ownership

bioAffinity Technologies, Inc. Filed Acc 0001493152-22-033932

Chief Financial Officer bought 2,448 shares

  • Chief Financial Officer acquired 2,243 shares (conversion)
  • Chief Financial Officer acquired 3,619 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Edwards James Michael · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-01 Purchase : show line 1 in the form +2,448 30,323 D
2022-09-06 Conversion : show line 2 in the form +2,243 $4.20 $9,421 32,566 D
2022-11-17 Grant or award : show line 3 in the form +3,619 36,815 D
Open-market purchases · 2,448 sh

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2022-09-01 Purchase : show line 4 in the form Warrants (right to buy) +2,448 2,448 D
2022-09-01 Purchase : show line 5 in the form Non-tradeable Warrants (right to buy) +2,448 2,448 D
2022-09-06 Conversion : show line 6 in the form Secured Convertible Promissory Note −0 0 D
2022-09-06 Grant or award : show line 7 in the form Warrant (right to buy) +1,903 1,903 D
2022-07-20 Grant or award : show line 8 in the form Warrant (right to buy) +761 761 D
Loading xslF345X03/ownership.xml…